The effects of age, apolipoprotein E phenotype and gender on the concentration of amyloid-beta (A beta) 40, A beta 4242, apolipoprotein E and transthyretin in human cerebrospinal fluid (Q47625100)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	The effects of age, apolipoprotein E phenotype and gender on the concentration of amyloid-beta (A beta) 40, A beta 4242, apolipoprotein E and transthyretin in human cerebrospinal fluid	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/9721442

The effects of age, apolipoprotein E phenotype and gender on the concentration of amyloid-beta (A beta) 40, A beta 4242, apolipoprotein E and transthyretin in human cerebrospinal fluid (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/9721442

cerebrospinal fluid

0 references

author name string

Kunicki S

1

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/9721442

Richardson J

2

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/9721442

Mehta PD

3

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/9721442

Kim KS

4

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/9721442

Zorychta E

5

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/9721442

publication date

1 July 1998

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/9721442

Clinical Biochemistry

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/9721442

31

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/9721442

5

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/9721442

409-415

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/9721442

Epidemiology of Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2898%2900027-7

7 January 2021

Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2898%2900027-7

7 January 2021

Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2898%2900027-7

7 January 2021

Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2898%2900027-7

7 January 2021

Observations on the brains of non-demented old people

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2898%2900027-7

7 January 2021

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2898%2900027-7

7 January 2021

Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2898%2900027-7

7 January 2021

Detection of soluble forms of the beta-amyloid precursor protein in human plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2898%2900027-7

7 January 2021

Isolation and quantification of soluble Alzheimer's beta-peptide from biological fluids

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2898%2900027-7

7 January 2021

The beta-amyloid protein precursor of Alzheimer disease has soluble derivatives found in human brain and cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2898%2900027-7

7 January 2021

Apolipoprotein E allele epsilon 4 is linked to increased deposition of the amyloid beta-peptide (A-beta) in cases with or without Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2898%2900027-7

7 January 2021

Apolipoprotein E, Dementia, and Cortical Deposition of β-Amyloid Protein

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2898%2900027-7

7 January 2021

The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2898%2900027-7

7 January 2021

Excessive production of amyloid beta-protein by peripheral cells of symptomatic and presymptomatic patients carrying the Swedish familial Alzheimer disease mutation

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2898%2900027-7

7 January 2021

Apolipoprotein E: binding to soluble Alzheimer's beta-amyloid

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2898%2900027-7

7 January 2021

Transthyretin sequesters amyloid beta protein and prevents amyloid formation

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2898%2900027-7

7 January 2021

Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2898%2900027-7

7 January 2021

Reduction of beta-amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2898%2900027-7

7 January 2021

Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2898%2900027-7

7 January 2021

Clinical relevance of the quantification of apolipoprotein E in cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2898%2900027-7

7 January 2021

Soluble amyloid beta-protein in the cerebrospinal fluid from patients with Alzheimer's disease, vascular dementia and controls.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2898%2900027-7

7 January 2021

Increased plasma amyloid beta protein 1-42 levels in Down syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2898%2900027-7

7 January 2021

Age-related changes in cerebrospinal fluid protein concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2898%2900027-7

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2898%2900027-7

7 January 2021

An age-related correlation between levels of beta-amyloid precursor protein and beta-amyloid in human cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2898%2900027-7

7 January 2021

Inconstant apolipoprotein E (ApoE)-like immunoreactivity in amyloid beta protein deposits: relationship with APOE genotype in aging brain and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2898%2900027-7

7 January 2021

Analysis of heterogeneous A4 peptides in human cerebrospinal fluid and blood by a newly developed sensitive Western blot assay

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2898%2900027-7

7 January 2021

Reduced prealbumin (transthyretin) in CSF of severely demented patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2898%2900027-7

7 January 2021

Transthyretin: a choroid plexus-specific transport protein in human brain. The 1986 S. Weir Mitchell award

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2898%2900027-7

7 January 2021

Relevance of the quantification of apolipoprotein E in the cerebrospinal fluid in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2898%2900027-7

7 January 2021

Characterization of beta-amyloid peptide from human cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2898%2900027-7

7 January 2021

Early-onset dementias: clinical, neuropathological and genetic characteristics

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2898%2900027-7

7 January 2021

Cerebrospinal fluid apolipoprotein E is reduced in Alzheimerʼs disease

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2898%2900027-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0009-9120(98)00027-7

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/9721442

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/9721442

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47625100&oldid=2163247536"